Trinity Biotech plc
TRIB
Rank in Stocks
#19377
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in... Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offerings encompasses diagnostic tests and specialized instrumentation for identifying numerous infectious diseases. These include Lyme disease, sexually transmitted infections like syphilis and herpes, SARS-CoV-2, and a variety of viral pathogens such as Epstein Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella. Additionally, Trinity Biotech provides in-vitro diagnostic products centered on haemoglobin A1c for the crucial monitoring, diagnosis, and risk assessment of diabetes. The company's product development incorporates diverse assay formats, including immunofluorescence, enzyme-linked immunosorbent (ELISA), Western blot, and line immunoassays. It also supplies a suite of reagent products, including ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase, vital for diagnosing liver and kidney disorders, as well as haemolytic anaemia. Beyond diagnostics, Trinity Biotech serves the life sciences industry and research facilities by supplying raw materials. The company's customer base comprises public health authorities, non-governmental organizations, and both clinical and reference laboratories. Its products are distributed through a dedicated direct sales force, complemented by a broad network of independent distributors and strategic partnerships.
Share Price
$5.34
Last synced: 2026-11-09
Market Cap
$108.17M
Change (1 day)
-6.29%
Change (1 year)
-80.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Trinity Biotech plc (TRIB)
Category
Healthcare
EPS for Trinity Biotech plc (TRIB)
EPS as of December 2025 TTM: $-60.60
According to Trinity Biotech plc's latest financial reports, its current EPS (TTM) is $-60.60. At the end of 2025 the company had an EPS of $-60.00, a decrease compared to its 2024 EPS of $-52.98.
EPS history for Trinity Biotech plc from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-60.60 | 1.00% |
| 2025 | $-60.00 | 13.25% |
| 2024 | $-52.98 | -44.81% |
| 2023 | $-96.00 | -46.67% |
| 2022 | $-180.00 | -2,957.14% |
| 2021 | $6.30 | -113.65% |
| 2020 | $-46.14 | 58.56% |
| 2019 | $-29.10 | -270.18% |
| 2018 | $17.10 | -106.12% |
| 2017 | $-279.30 | -57.51% |
| 2016 | $-657.30 | -2,382.29% |
| 2015 | $28.80 | 26.32% |
| 2014 | $22.80 | 72.73% |
| 2013 | $13.20 | -45.68% |
| 2012 | $24.30 | 10.96% |
| 2011 | $21.90 | -74.39% |
| 2010 | $85.50 | 26.11% |
| 2009 | $67.80 | -111.83% |
| 2008 | $-573.30 | 105.48% |
| 2007 | $-279.00 | -4,750.00% |
| 2006 | $6.00 | -44.44% |
| 2005 | $10.80 | -77.50% |
| 2004 | $48.00 | -23.08% |
| 2003 | $62.40 | 8.33% |
| 2002 | $57.60 | 236.84% |
| 2001 | $17.10 | -72.60% |
| 2000 | $62.40 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -131.34% |
US
|
|
| $6.12 | -110.10% |
US
|
|
| $1.38 | -102.27% |
CN
|
|
| $14.83 | -124.47% |
US
|
|
| $5.09 | -108.40% |
US
|
Questions about Trinity Biotech plc's earnings per share (EPS)
What is Trinity Biotech plc's earnings per share (EPS)?
Trinity Biotech plc's earnings per share (EPS) over the last twelve months is $-60.60, as of Dec 2025.
What was Trinity Biotech plc's earnings per share (EPS) in 2025?
In 2025, Trinity Biotech plc's earnings per share (EPS) was $-60.00, compared with $-52.98 in 2024.
How has Trinity Biotech plc's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Trinity Biotech plc's earnings per share (EPS) was highest in 2021 ($6.30) and lowest in 2022 ($-180.00).
How does Trinity Biotech plc's earnings per share (EPS) compare with similar companies?
Trinity Biotech plc's earnings per share (EPS) ($-60.60) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.